Aktieanalys

Amniotics Q4’21: Continuing the Development of Lung Indications - Redeye

{newsItem.title}

Redeye Publicerad: 17 Feb 2022 13:25

Redeye provides a comment on Amniotics’ Q4 report.

Länk till analysen i sin helhet: https://www.redeye.se/research/833419/amniotics-q421-continuing-the-development-of-lung-indications?utm_source=finwire&utm_medium=RSS

Nyheter om Amniotics

Läses av andra just nu

Om aktien Amniotics

Senaste nytt